The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A phase Il trial to assess the impact of ß2 adrenergic receptor (ß2-AR) blockade in metastatic triple negative breast cancer (mTNBC).
 
Shipra Gandhi
Honoraria - Aptitude Health; OncLive/MJH Life Sciences
Consulting or Advisory Role - AstraZeneca; Hologic/Biotheranostics; MedPage Today; Novartis; Peerview
Speakers' Bureau - Roche
Travel, Accommodations, Expenses - MJH Life Sciences; Roche
 
Lindsay Moshides
No Relationships to Disclose
 
Hans Minderman
No Relationships to Disclose
 
Hemn Mohammadpour
No Relationships to Disclose
 
Spencer Rosario
No Relationships to Disclose
 
Kevin Kalinsky
Employment - EQRx (I)
Stock and Other Ownership Interests - EQRx (I)
Consulting or Advisory Role - AstraZeneca; bioTheranostics; Cullinan Oncology; Daiichi Sankyo/Astra Zeneca; eFFECTOR Therapeutics; Genentech/Roche; Gilead Sciences; Lilly; Menarini Silicon Biosystems; Merck; mersana; Mersana; Myovant Sciences; Novartis; Pfizer; Prelude Therapeutics; ProteinQure; Puma Biotechnology; RayzeBio; Regor; Relay Therapeutics; Takeda
Research Funding - Ascentage Pharma (Inst); AstraZeneca (Inst); Daichi Sankyo (Inst); Genentech/Roche (Inst); Lilly (Inst); Novartis (Inst); Seagen (Inst)
 
Elizabeth Repasky
No Relationships to Disclose